SEC closes Sinovac investigation

Clara Hudson

20 August 2018

The US Securities and Exchange Commission. Scott S on Flickr (CC BY 2.0)

Chinese vaccine developer Sinovac Biotech has announced that the SEC dropped an investigation into potentially improper payments to Chinese officials.

Subscribe to Global Investigations Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.

Subscribe now

Already have access? Login below

Clara Hudson

View full biography

Author

[email protected]

Unlock unlimited access to all Global Investigations Review content